title: The year in atherothrombosis.
authors.affiliation: Zena and Michael A. Wiener Cardiovascular Institute/Marie-Josée and Henry R. Kravis Center for Cardiovascular Health, Mount Sinai School of Medicine, New York, NY, USA.
authors.forename: Javier
authors.initials: J
authors.lastname: Sanz
authors.forename: Pedro R
authors.initials: PR
authors.lastname: Moreno
authors.forename: Valentin
authors.initials: V
authors.lastname: Fuster
mesh_terms: D000818:Animals; D050197:Atherosclerosis / Q000150:complications* / Q000175:diagnosis* / Q000188:drug therapy / Q000453:epidemiology / Q000503:physiopathology / Q000517:prevention & control; D015415:Biomarkers / Q000097:blood; D002317:Cardiovascular Agents / Q000008:administration & dosage* / Q000191:economics; D048909:Diabetes Complications / Q000150:complications / Q000175:diagnosis; D050171:Dyslipidemias / Q000097:blood / Q000150:complications / Q000188:drug therapy; D042241:Early Diagnosis; D005343:Fibrinolytic Agents / Q000008:administration & dosage; D014943:Global Health; D015438:Health Behavior; D017048:Health Care Costs; D006710:Homocysteine / Q000097:blood; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000008:administration & dosage; D020138:Hyperhomocysteinemia / Q000150:complications / Q000175:diagnosis; D006973:Hypertension / Q000150:complications / Q000175:diagnosis; D008279:Magnetic Resonance Imaging; D055118:Medication Adherence; D058226:Plaque, Atherosclerotic / Q000150:complications / Q000175:diagnosis; D012307:Risk Factors; D040242:Risk Reduction Behavior; D015607:Stents / Q000009:adverse effects; D013927:Thrombosis / Q000453:epidemiology / Q000209:etiology* / Q000517:prevention & control*; D014481:United States / Q000453:epidemiology
chemical_list: D015415:Biomarkers; D002317:Cardiovascular Agents; D005343:Fibrinolytic Agents; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors; D006710:Homocysteine